Homebiotech

biotech

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Kither Biotech completes phase 1 trial of inhaled peptide therapy for respiratory diseases

Jim Cornall - June 22, 2026

biotech

Houdini Bio launches to solve therapeutic and commercial genetic medicine bottlenecks

Jim Cornall - June 22, 2026

biotech

Base to Base biotech podcast 64: Solving logistics challenges

Jim Cornall - June 19, 2026

biotech

Preclinical results for novel therapeutic candidate for rare neurodevelopmental disorders

Jim Cornall - June 18, 2026

biotech

Breakthrough in personalised treatments for lung cancer

Jim Cornall - June 18, 2026

biotech

Gene therapy prolongs health span

Jim Cornall - June 18, 2026

biotech

CancerVax demonstrates full nanoparticle delivery

Jim Cornall - June 17, 2026

biotech

Nuvalent to be acquired by GSK for $10.6bn

Jim Cornall - June 17, 2026

1...111213...96 Page 12 of 96

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026 0

On a genetic level, RNA viruses share common structural elements. The RNA of their genomes has strings, folds, and knot-like features that interact with...

Base to Base biotech podcast 72: Cell-free DNA bioproduction

biotech Jim Cornall - August 21, 2026 0

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0